Advertisement
Screener

Sunshine Biopharma Inc. (SBFM) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Sunshine Biopharma Inc. Cash Flow Breakdown

Cash flow breakdown shows where Sunshine Biopharma Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $5.33M went out.
  • Fiscal year ended 2025-12-31: from investing, $836.31K went out.
  • Fiscal year ended 2025-12-31: from financing, $4.75M came in.
  • Fiscal year ended 2025-12-31: change in cash, $1.42M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksCommercial paperNew shares soldNot split outChange in cash
2025-12-31-$5.33M-$836.31K$0.00$1.83M$2.92M*-$1.42M
2024-12-31-$12.52M-$1.98M-$3.14M*$8.52M-$5.56M
2023-12-31-$8.78M-$656.15K-$541.14K$4.09M-$6.01M
2022-12-31-$5.25M-$14.62M$0.00$30.37M$9.10M*$19.60M
2021-12-31-$1.83M$0.00$61.50K$0.00$2.84M*$1.08M
2020-12-31-$657.30K-$1.19K$40.61K$1.57M*$949.76K
2019-12-31-$495.80K-$15.28K-$68.82K
2018-12-31-$512.81K-$13.91K$0.00$527.64K*$926.00
2017-12-31-$543.52K-$84.01K$63.91K$606.79K*$43.18K
2016-12-31-$314.18K-$3.44K$104.13K$7.00K
2015-12-31-$867.64K-$623.60K$236.55K$1.16M*-$92.63K
2014-12-31-$538.60K$0.00$153.33K$112.18K
2013-12-31-$564.40K$0.00$0.00-$101.40K
2012-12-31-$393.05K$0.00$402.50K$71.95K
2011-12-31-$297.30K$0.00$195.60K-$101.70K
2010-12-31-$348.32K$0.00$398.60K$50.27K

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksCommercial paperNew shares soldNot split outChange in cash
2026-06-30-$917.98K*-$5.12K*$7.80M*
2026-03-31-$2.07M-$104.52K-$2.18M
2025-12-31-$1.62M*-$50.21K*$0.00*$0.00*$724.50K*
2025-09-30-$746.67K*-$23.89K*$0.00*$0.00*
2025-06-30-$1.27M*-$550.19K*$0.00*$1.83M*$1.84M*
2025-03-31-$1.70M-$212.02K$0.00$0.00-$1.55M
2024-12-31-$3.41M*-$97.77K*$0.00*$0.00*$1.62M*
2024-09-30-$1.36M*-$670.60K*$0.00*$0.00*$1.95M*
2024-06-30-$4.58M*-$542.21K*$0.00*$0.00*
2024-03-31-$3.19M-$668.74K-$3.14M$8.52M$1.54M
2023-12-31-$2.69M*-$269.23K*$0.00*$0.00*
2023-09-30-$457.29K*$18.86K*$10.00*
2023-06-30-$3.78M*-$259.48K*$4.09M*
2023-03-31-$1.85M-$146.30K$0.00-$538.30K*-$2.53M
2022-12-31-$2.25M*-$14.62M*-$13.19M*$11.10M*
2022-09-30-$1.12M*$0.00*$0.00*
2022-06-30-$573.80K*$0.00*$29.12M*
2022-03-31-$1.30M$0.00$14.44M-$2.00M*$11.13M
2021-12-31-$312.11K*$0.00*$0.00*
2021-09-30-$600.81K*$0.00*$1.28M*
2021-06-30-$618.85K*$550.65K*
2021-03-31-$297.36K$0.00$1.10M*$804.64K
2020-12-31-$423.67K*-$391.00*$33.61K*$891.00K*$500.55K*
2020-09-30-$120.58K*-$800.00*$3.00K*$521.64K*$403.26K*
2020-06-30-$82.02K*$0.00*$76.99K*
2020-03-31-$31.03K$0.00-$31.03K
2019-12-31-$127.84K*-$860.00*-$38.54K*
2019-09-30-$86.54K*-$1.44K*$44.70K*
2019-06-30-$47.46K*-$12.98K*-$55.67K*
2019-03-31-$233.96K$0.00-$19.30K
2018-12-31-$116.05K*$8.52K*$65.26K*
2018-09-30-$170.88K*$80.23K*$1.02K*
2018-06-30-$57.43K*-$22.53K*-$65.32K*
2018-03-31-$168.46K-$80.13K-$31.00
2017-12-31-$209.48K*-$84.01K*$0.00*-$79.33K*
2017-09-30-$148.19K*$22.30K*$0.00*$54.98K*
2017-06-30-$77.81K*-$22.30K*$63.91K*$109.34K*
2017-03-31-$108.04K$0.00$0.00-$41.82K
2016-12-31-$31.19K*-$1.10K*$0.00*$37.04K*
2016-09-30-$62.99K*$0.00*$0.00*-$51.83K*
2016-06-30-$138.40K*-$2.34K*$25.00K*-$60.74K*
2016-03-31-$81.60K$0.00$79.13K$82.53K
2015-12-31-$342.79K*-$623.60K*$0.00*$893.09K*-$73.30K*
2015-09-30-$102.61K*$0.00*$0.00*-$28.77K*
2015-06-30-$309.25K*$0.00*$118.28K*$4.17K*
2015-03-31-$113.00K$0.00$118.28K$5.28K
2014-12-31-$247.71K*$0.00*$43.33K*-$30.43K*
2014-09-30-$18.05K*$0.00*$100.00K*$135.45K*
2014-06-30-$182.05K*$0.00*$0.00*-$32.05K*
2014-03-31-$90.78K$0.00$10.00K$39.22K
2013-12-31-$39.75K*$0.00*$0.00*-$39.75K*
2013-09-30-$85.64K*$0.00*$0.00*-$85.64K*
2013-06-30-$99.28K*-$99.28K*
2013-03-31-$339.72K$123.28K
2012-12-31-$172.78K*$0.00*$0.00*-$122.78K*
2012-09-30-$160.33K*$0.00*$352.50K*$192.17K*
2012-06-30-$25.19K*$0.00*$50.00K*$24.81K*
2012-03-31-$34.76K$0.00$0.00-$22.26K
2011-12-31-$117.78K*$0.00*$0.00*-$117.78K*
2011-09-30-$118.37K*$0.00*$195.60K*$77.23K*
2011-06-30-$61.15K$0.00$0.00-$61.15K
2011-03-31-$44.33K$0.00$0.00-$44.33K
2010-12-31$120.83K*$0.00*-$250.40K*-$129.57K*
2010-06-30-$95.83K$0.00$0.00-$95.83K
2010-03-31-$1.28M$0.00$0.00-$1.28M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aptevo Therapeutics Inc. (APVO)United States$0.003B
Alaunos Therapeutics, Inc. (TCRT)United States$0.003B-1.44
Genprex, Inc. (GNPX)United States$0.003B-0.02
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Onconetix, Inc. (ONCO)United States$0.004B
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
HCW Biologics Inc. (HCWB)United States$0.004B-6.15
REVELATION BIOSCIENCES, INC. (REVB)United States$0.004B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B